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Abstract
Acute exposure of sensitized mice to antigen elicits allergic airway disease (AAD) characterized by
Th2 cytokine-dependent pulmonary eosinophilia, methacholine hyperresponsiveness and antigen-
specific IgE elevation. However, chronic exposure induces a local inhalational tolerance (LIT), with
resolution of the airway responses but persistent systemic IgE production. To further determine if
systemic immunologic responses were maintained during LIT, we assessed subcutaneous late phase
responses to ovalbumin in this model. Sensitized and AAD mice developed small subcutaneous
responses to ovalbumin, with footpad thickness increasing to 113.7 and 113.6% of baseline,
respectively. In comparison, LIT mice developed marked foot swelling (141.6%). Histologic
examination confirmed increased inflammation in the chronic animals, with a significant contribution
by eosinophils. Thus, the resolution of airway inflammatory responses with chronic antigen
inhalation is a localized response, not associated with loss of systemic responses to antigen.
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In antigen-sensitized humans and animals, inhalational exposure to the antigen can induce
allergic airway disease (AAD), or asthma, characterized by eosinophilic airway inflammation,
elaboration of Th2 cytokines and airway hyperresponsiveness. Such individuals also
demonstrate systemic responses to antigen, including elevated levels of antigen-specific IgE.
Numerous murine models exist in which inhalation of allergens in sensitized mice induces
Th2-driven eosinophilic airway disease. We1,2 and others3-5 have shown that, in contrast to
human subjects, mice exposed chronically to inhaled antigen can reverse their established
airway inflammation and hyperresponsiveness, and develop what we have termed local
inhalational tolerance (LIT). LIT is dependent upon continuous antigen exposure2 and is
associated with the persistence of CD4+CD25+Foxp3+ regulatory T cells in the lung and
regional lymph nodes6 and the establishment of bystander tolerance to unrelated antigens.2,5
We emphasized the term ‘local’ because despite resolution of the airway eosinophilia and Th2
cytokine production, systemic IgE responses to antigen are sustained.2 Although the
persistence of the systemic IgE response has also been observed in other chronic inhalational
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models,5 it is not a uniform finding in sensitized mice chronically exposed to antigen.3,4 The
maintenance of antigen-specific IgE elevation in the absence of airway inflammatory responses
in LIT mice suggests that this form of inhalational tolerance is dependent upon local regulatory
mechanisms rather than systemic lymphocyte clonal deletion or anergy. In addition, if chronic
aerosolized antigen exposure induces clonal deletion or the development of a dominant,
antigen-specific, inhibitory T-cell population, tolerance should be sustained in the absence of
antigen or recalled with re-exposure to antigen. We found that such sustained tolerance did not
occur in the absence of antigen, as interrupting ovalbumin (OVA) aerosol challenges for 4
weeks after establishment of the 6-week tolerant stage followed by re-exposure to OVA
aerosols resulted in development of AAD.2 Although the above observations suggest that LIT
is a regional response localized to the respiratory tract, they do not exclude the concomitant
attenuation of systemic responses. Thus, the present study was designed to determine if
systemic responses to antigen in sensitized mice were sustained in the presence of LIT.
RESULTS AND DISCUSSION
As shown in Figure 1, naïve and alum-only mice developed no foot swelling following local
injection of OVA (post-OVA thickness 100.8 and 100.7% of baseline, respectively). OVA-
sensitized/non-aerosol exposed mice, OVA-sensitized/OVA-exposed (AAD) mice, and OVA-
sensitized/BSA-exposed (bovine serum albumin, BSA) mice showed modest but statistically
significant delayed-type hypersensitivity responses, to 113.7, 113.6 and 110.5% of baseline,
respectively (95% CI 111.5-115.8%, 111.2-115.9% and 108.3-112.8%; P<0.0001, P<0.0001
and P=0.0007 by paired t-tests). In comparison, LIT mice developed marked foot swelling, to
141.6% of baseline (95% CI 127.1-156.1%; P=0.0003) and significantly increased from
responses in the sensitized, AAD and BSA animals (P<0.0001 by analysis of variance).
Histologic examination of the footpads confirmed that edema was representative of
subcutaneous LPRs (late-phase responses). Tissues from sensitized and from AAD mice
showed mild edema and perivascular inflammation, containing a mixed proportion of
mononuclear cells and few eosinophils. These changes were qualitatively more pronounced in
footpads from LIT mice, which consistently demonstrated increased edema, inflammation and
eosinophilic infiltrates, along with areas of hemorrhage consistent with marked tissue
inflammation (Figure 2).
Inflammatory responses occurring in subcutaneous LPRs are similar to those involved in
allergic asthma and rhinitis.7 Subcutaneous LPRs are dependent upon antigen-specific IgE.8,
9 In addition, T lymphocytes and activated eosinophils accumulate at subcutaneous LPR sites
between 6 and 48 h after allergen injection.10 There is an association in allergic human subjects
between CD4+ T-cell numbers and the persistence of activated eosinophils, suggesting that T
cells are actively participating in the inflammatory process.10 Similarly, whereas classical
delayed-type hypersensitivity is mediated by Th1 lymphocytes secreting predominantly IFN-
γ and IL-2, subcutaneous LPRs to OVA given to mice without Freund's adjuvant are
characterized by eosinophilic inflammation, mixed production of Th2 (IL-4 and IL-5) and Th1
(IFN-γ) cytokines and possible generation of Th2 (IgG1) and Th1 (IgG2) antibody isotype
responses.11
There are several models of antigen-specific tolerance that are established in naïve animals
before antigen sensitization12-17 or in sensitized animals prior to the development of AAD.
18,19 The phenomenon of LIT differs significantly from the these tolerance models, in that it
is established in the presence of AAD and serves to abrogate the allergic inflammatory
responses and re-establish airway homeostasis. It is able to exert bystander protection against
inflammatory responses to unrelated antigens. More importantly, it is a focal process, with
tolerance localized to the lung but not to systemic responses. Although the above tolerance
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models inhibit antigen-specific IgE production, OVA-specific IgE and IgG1 remain elevated
in our model.2 It is likely that the continued production of these antibodies contributes to the
subcutaneous LPR in the present study. Moreover, the strongly positive LPR in LIT animals
indicates that there remains a sizeable and perhaps increased pool of circulating CD4+ effector
T cells that can respond to OVA during LIT. The attenuation of lung and airway responses
during LIT may be attributed to the localization or focal expansion of CD4+CD25+Foxp3+
regulatory T cells in pulmonary compartments and regional lymph nodes.6 The absence of
such regulatory T cells in the spleen or inguinal lymph nodes6 could allow circulating OVA-
specific CD4+ effector T cells to generate a subcutaneous LPR to antigen.
In summary, the development of LIT with chronic aerosol exposure to OVA was not associated
with loss of systemic effects to antigen. On the contrary, the subcutaneous LPR was enhanced,
despite ablation of AAD. These findings support the regional nature of LIT and suggest that
LIT represents a critical process for the control of allergic airways disease. The further
elucidation of mechanisms underlying LIT may have major implications for the re-
establishment of airway tolerance in allergic individuals with asthma.
METHODS
Animals
Adult (6-8 week) female C57BL/6J mice were purchased from the Jackson Laboratory (Bar
Harbor, ME, USA). All work was approved by our institutional animal care committee, and
animal welfare was in accordance with the ‘Guide for the Care and Use of Laboratory Animals’.
20
OVA exposure protocol
Mice were sensitized and challenged to ovalbumin (OVA), as described previously.2 Briefly,
animals first received 3 weekly intraperitoneal injections of 25 µg OVA (grade V; Sigma
Chemical Co., St Louis, MO, USA) and 2 mg aluminum hydroxide (alum). One week after the
last injection, the mice were exposed to 1% aerosolized OVA either for 1 h/day for 7 days
(AAD group), or for 1 h per day for 7 days followed by 5 days per week for 6 weeks (LIT
group). The OVA aerosols were generated by a BANG nebulizer (CH Technologies,
Westwood, NJ, USA) into a 7.6-L, 48-port inhalation exposure chamber, to which mice placed
in plastic restraint tubes were attached (CH Technologies). Control mice included animals that
received intraperitoneal alum without OVA and animals that were sensitized to OVA/alum and
subsequently exposed to 1% aerosolized BSA for 7 days using a different BANG nebulizer
and aerosol chamber.
Subcutaneous LPR and histology
Naïve mice, sensitized/non-aerosol-exposed mice, AAD mice and LIT mice all received
intradermal injections of 30 µl of PBS containing 100 µg OVA into the left hind footpad.
Twenty-four hours later, the mice were anesthetized (ketamine 90 mg kg−1 and xylazine 10
mg kg−1), and the thickness of the injected and non-injected footpads was measured with a
digital micrometer. After animal sacrifice, the injected feet were removed, fixed with 10%
buffered formalin and processed in a standard manner. Tissue sections were stained with
hematoxylin and eosin. Sections from all animals were examined in a blinded manner by one
of the investigators (TVR), and representative areas were photographed.
Statistical analysis
Changes in footpad thickness before and after OVA injection were made by paired t-tests and
were compared between groups by repeated measures analysis of variance (StatView 4.5,
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Abacus Concepts, Inc., Berkeley, CA, USA). Differences were considered significant at
P<0.05.
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Subcutaneous late phase responses in mice before and after footpad injection with OVA. (a)
Footpad thicknesses were measured by a digital micrometer before (gray bars) and 24h after
(black bars) local injection of OVA. Thickness did not change in naïve mice or mice given
only intraperitoneal alum. Footpad thickness increased 10-14% in OVA-sensitized/non-
aerosol challenged mice (Sens), OVA-sensitized/OVA-aerosol mice (AAD) and OVA-
sensitized/BSA-aerosol mice (BSA). The swelling was significantly greater in LIT mice,
increasing 42% above baseline thickness. Data represent mean±s.e. values; n=5-10 in each
group. (b) Photographs of representative subcutaneous LPRs at baseline (upper photos) and
24h after OVA injection (lower photos) in a naïve, OVA-sensitized/non-aerosol (sensitized),
alum-sensitized, OVA-sensitized/OVA-aerosol (AAD), OVA-sensitized/BSA-aerosol (BSA)
and LIT mouse. *P<0.001 vs pre-OVA injection thickness; †P<0.0001 vs other post-OVA
responses. AAD, allergic airway disease; BSA, bovine serum albumin; LIT, local inhalational
tolerance; LPRs, late-phase responses; OVA, ovalbumin.
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Histology of the footpad late phase responses in representative mice. Relative to naïve mice
(a), sensitized and AAD mice (b and c) showed mild degrees of edema and perivascular
inflammation. These responses were more pronounced in LIT mice, which demonstrated
marked edema and areas of hemorrhage (d), and increased inflammation containing
mononuclear cells and eosinophils (e; arrows identify eosinophils). Magnification ×20 (a-d)
and ×60 (e). AAD, allergic airway disease; LIT, local inhalational tolerance.
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